Song He

1.5k total citations
49 papers, 1.0k citations indexed

About

Song He is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Song He has authored 49 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Oncology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Song He's work include Lymphoma Diagnosis and Treatment (10 papers), Pancreatic and Hepatic Oncology Research (5 papers) and RNA Research and Splicing (5 papers). Song He is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Pancreatic and Hepatic Oncology Research (5 papers) and RNA Research and Splicing (5 papers). Song He collaborates with scholars based in China, United States and South Korea. Song He's co-authors include Ming Dong, Shougang Zhuang, Na Liu, George Bayliss, Weiwei Sheng, Jianping Zhou, Yuchan Wang, Evelyn Tolbert, Yaxun Wu and Xiaobing Miao and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Annals of Oncology.

In The Last Decade

Song He

45 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Song He China 19 615 321 208 136 122 49 1.0k
Shujun Lin China 16 822 1.3× 354 1.1× 179 0.9× 80 0.6× 206 1.7× 49 1.4k
Fenghua Zeng United States 14 571 0.9× 244 0.8× 137 0.7× 68 0.5× 140 1.1× 24 1.1k
Yanping Gong China 21 517 0.8× 219 0.7× 201 1.0× 266 2.0× 86 0.7× 54 1.1k
Nur Buyru Türkiye 18 605 1.0× 291 0.9× 201 1.0× 105 0.8× 93 0.8× 63 1.0k
Ning Liu China 20 428 0.7× 242 0.8× 148 0.7× 88 0.6× 156 1.3× 97 1.0k
Vera Roginskaya United States 18 682 1.1× 191 0.6× 137 0.7× 69 0.5× 60 0.5× 28 1.1k
Jack Leslie United Kingdom 17 396 0.6× 184 0.6× 208 1.0× 93 0.7× 117 1.0× 34 1.1k
Yasumichi Inoue Japan 22 1.2k 2.0× 544 1.7× 305 1.5× 131 1.0× 121 1.0× 56 1.8k
Yuanjun Jiang China 18 365 0.6× 117 0.4× 175 0.8× 88 0.6× 111 0.9× 47 734

Countries citing papers authored by Song He

Since Specialization
Citations

This map shows the geographic impact of Song He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Song He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Song He more than expected).

Fields of papers citing papers by Song He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Song He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Song He. The network helps show where Song He may publish in the future.

Co-authorship network of co-authors of Song He

This figure shows the co-authorship network connecting the top 25 collaborators of Song He. A scholar is included among the top collaborators of Song He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Song He. Song He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hu, Jing, et al.. (2025). Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor After Imatinib Resistance. Pharmaceutics. 17(7). 923–923.
3.
Wei, Yong, Jiachun Zhang, Yang‐Chang Wu, et al.. (2024). Identification of Mycobacterium marinum in subcutaneous abscesses of an infected patient's foot. The Journal of Infection in Developing Countries. 18(11). 1787–1792.
4.
Song, Guoqiang, Song He, Jie Jiang, et al.. (2023). 683P Preclinical evaluation of HLX42, a novel EGFR-targeting ADC, for cetuximab or TKI resistant cancer. Annals of Oncology. 34. S477–S478. 4 indexed citations
5.
Huang, Yuejiao, Yuchan Wang, Jie Tang, et al.. (2021). CAM-DR: Mechanisms, Roles and Clinical Application in Tumors. Frontiers in Cell and Developmental Biology. 9. 698047–698047. 19 indexed citations
7.
Dai, Kui, et al.. (2019). Expression of PD-1 and PD-L1 in diffuse large B-cell lymphoma. 35(4). 379–382. 1 indexed citations
8.
Sheng, Weiwei, Ming Dong, Guosen Wang, et al.. (2019). The diversity between curatively resected pancreatic head and body-tail cancers based on the 8th edition of AJCC staging system: a multicenter cohort study. BMC Cancer. 19(1). 981–981. 18 indexed citations
10.
Huang, Yuejiao, Jie Tang, Shan Shao, et al.. (2019). Role of Apg-1 in HSF1 activation and bortezomib sensitivity in myeloma cells. Experimental Hematology. 81. 50–59. 3 indexed citations
11.
Sheng, Weiwei, Chuanping Chen, Ming Dong, et al.. (2017). Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway. Cell Death and Disease. 8(10). e3147–e3147. 125 indexed citations
12.
Zhu, Xinghua, Yaxun Wu, Xiaobing Miao, et al.. (2016). High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma. Tumor Biology. 37(11). 14615–14628. 40 indexed citations
13.
Miao, Xiaobing, Yaxun Wu, Yingze Wei, et al.. (2016). The role of the Chaperonin containing t-complex polypeptide 1, subunit 8 (CCT8) in B-cell non-Hodgkin's lymphoma. Leukemia Research. 45. 59–67. 15 indexed citations
15.
Wang, Yuchan, Yaxun Wu, Xiaobing Miao, et al.. (2015). Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma. International Journal of Biological Macromolecules. 81. 809–817. 14 indexed citations
16.
Ni, Runzhou, Qingchun Deng, Xiaodong Huang, et al.. (2013). Glyoxylate Reductase/Hydroxypyruvate Reductase: A Novel Prognostic Marker for Hepatocellular Carcinoma Patients after Curative Resection. Pathobiology. 80(3). 155–162. 8 indexed citations
17.
Wang, Wenwen, Song He, Juling Ji, et al.. (2013). The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma. Pathology - Research and Practice. 209(6). 353–358. 28 indexed citations
18.
Chen, Hongwei, Xiaodong Huang, Song He, et al.. (2012). Expression of FOXJ1 in hepatocellular carcinoma: Correlation with patients' prognosis and tumor cell proliferation. Molecular Carcinogenesis. 52(8). 647–659. 38 indexed citations
19.
Zhang, Yuquan, Peng Chen, Gang Wu, et al.. (2011). Expression of NLK and Its Potential Effect in Ovarian Cancer Chemotherapy. International Journal of Gynecological Cancer. 21(8). 1380–1387. 26 indexed citations
20.
Jiang, Ying, Lin Zou, Chunhui Zhang, et al.. (2009). PPARγ and Wnt/β-Catenin pathway in human breast cancer: expression pattern, molecular interaction and clinical/prognostic correlations. Journal of Cancer Research and Clinical Oncology. 135(11). 1551–1559. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026